These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

349 related articles for article (PubMed ID: 21880910)

  • 1. Neuronal production of transthyretin in human and murine Alzheimer's disease: is it protective?
    Li X; Masliah E; Reixach N; Buxbaum JN
    J Neurosci; 2011 Aug; 31(35):12483-90. PubMed ID: 21880910
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The systemic amyloid precursor transthyretin (TTR) behaves as a neuronal stress protein regulated by HSF1 in SH-SY5Y human neuroblastoma cells and APP23 Alzheimer's disease model mice.
    Wang X; Cattaneo F; Ryno L; Hulleman J; Reixach N; Buxbaum JN
    J Neurosci; 2014 May; 34(21):7253-65. PubMed ID: 24849358
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms of transthyretin inhibition of β-amyloid aggregation in vitro.
    Li X; Zhang X; Ladiwala AR; Du D; Yadav JK; Tessier PM; Wright PE; Kelly JW; Buxbaum JN
    J Neurosci; 2013 Dec; 33(50):19423-33. PubMed ID: 24336709
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transthyretin accelerates vascular Abeta deposition in a mouse model of Alzheimer's disease.
    Wati H; Kawarabayashi T; Matsubara E; Kasai A; Hirasawa T; Kubota T; Harigaya Y; Shoji M; Maeda S
    Brain Pathol; 2009 Jan; 19(1):48-57. PubMed ID: 18429966
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transthyretin Suppresses Amyloid-β Secretion by Interfering with Processing of the Amyloid-β Protein Precursor.
    Li X; Song Y; Sanders CR; Buxbaum JN
    J Alzheimers Dis; 2016 Apr; 52(4):1263-75. PubMed ID: 27079720
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Accelerated Abeta deposition in APPswe/PS1deltaE9 mice with hemizygous deletions of TTR (transthyretin).
    Choi SH; Leight SN; Lee VM; Li T; Wong PC; Johnson JA; Saraiva MJ; Sisodia SS
    J Neurosci; 2007 Jun; 27(26):7006-10. PubMed ID: 17596449
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transthyretin and the brain re-visited: is neuronal synthesis of transthyretin protective in Alzheimer's disease?
    Li X; Buxbaum JN
    Mol Neurodegener; 2011 Nov; 6():79. PubMed ID: 22112803
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The type of Aβ-related neuronal degeneration differs between amyloid precursor protein (APP23) and amyloid β-peptide (APP48) transgenic mice.
    Rijal Upadhaya A; Scheibe F; Kosterin I; Abramowski D; Gerth J; Kumar S; Liebau S; Yamaguchi H; Walter J; Staufenbiel M; Thal DR
    Acta Neuropathol Commun; 2013 Nov; 1(1):77. PubMed ID: 24252227
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transthyretin stabilization by iododiflunisal promotes amyloid-β peptide clearance, decreases its deposition, and ameliorates cognitive deficits in an Alzheimer's disease mouse model.
    Ribeiro CA; Oliveira SM; Guido LF; Magalhães A; Valencia G; Arsequell G; Saraiva MJ; Cardoso I
    J Alzheimers Dis; 2014; 39(2):357-70. PubMed ID: 24169237
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transthyretin stability is critical in assisting beta amyloid clearance- Relevance of transthyretin stabilization in Alzheimer's disease.
    Alemi M; Silva SC; Santana I; Cardoso I
    CNS Neurosci Ther; 2017 Jul; 23(7):605-619. PubMed ID: 28570028
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dispersible amyloid β-protein oligomers, protofibrils, and fibrils represent diffusible but not soluble aggregates: their role in neurodegeneration in amyloid precursor protein (APP) transgenic mice.
    Rijal Upadhaya A; Capetillo-Zarate E; Kosterin I; Abramowski D; Kumar S; Yamaguchi H; Walter J; Fändrich M; Staufenbiel M; Thal DR
    Neurobiol Aging; 2012 Nov; 33(11):2641-60. PubMed ID: 22305478
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of amyloid β aggregate maturation on antibody treatment in APP23 mice.
    Balakrishnan K; Rijal Upadhaya A; Steinmetz J; Reichwald J; Abramowski D; Fändrich M; Kumar S; Yamaguchi H; Walter J; Staufenbiel M; Thal DR
    Acta Neuropathol Commun; 2015 Jul; 3():41. PubMed ID: 26141728
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amyloid-β protein modulates the perivascular clearance of neuronal apolipoprotein E in mouse models of Alzheimer's disease.
    Rolyan H; Feike AC; Upadhaya AR; Waha A; Van Dooren T; Haass C; Birkenmeier G; Pietrzik CU; Van Leuven F; Thal DR
    J Neural Transm (Vienna); 2011 May; 118(5):699-712. PubMed ID: 21210284
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Possible involvement of transthyretin in hippocampal beta-amyloid burden and learning behaviors in a mouse model of Alzheimer's disease (TgCRND8).
    Doggui S; Brouillette J; Chabot JG; Farso M; Quirion R
    Neurodegener Dis; 2010; 7(1-3):88-95. PubMed ID: 20173334
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transthyretin participates in beta-amyloid transport from the brain to the liver--involvement of the low-density lipoprotein receptor-related protein 1?
    Alemi M; Gaiteiro C; Ribeiro CA; Santos LM; Gomes JR; Oliveira SM; Couraud PO; Weksler B; Romero I; Saraiva MJ; Cardoso I
    Sci Rep; 2016 Feb; 6():20164. PubMed ID: 26837706
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ryanodine receptor blockade reduces amyloid-β load and memory impairments in Tg2576 mouse model of Alzheimer disease.
    Oulès B; Del Prete D; Greco B; Zhang X; Lauritzen I; Sevalle J; Moreno S; Paterlini-Bréchot P; Trebak M; Checler F; Benfenati F; Chami M
    J Neurosci; 2012 Aug; 32(34):11820-34. PubMed ID: 22915123
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transthyretin protects Alzheimer's mice from the behavioral and biochemical effects of Abeta toxicity.
    Buxbaum JN; Ye Z; Reixach N; Friske L; Levy C; Das P; Golde T; Masliah E; Roberts AR; Bartfai T
    Proc Natl Acad Sci U S A; 2008 Feb; 105(7):2681-6. PubMed ID: 18272491
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Divergent Age-Dependent Conformational Rearrangement within Aβ Amyloid Deposits in APP23, APPPS1, and
    Parvin F; Haglund S; Wegenast-Braun B; Jucker M; Saito T; Saido TC; Nilsson KPR; Nilsson P; Nyström S; Hammarström P
    ACS Chem Neurosci; 2024 May; 15(10):2058-2069. PubMed ID: 38652895
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Asymmetric expression patterns of brain transthyretin in normal mice and a transgenic mouse model of Alzheimer's disease.
    Tsai KJ; Yang CH; Lee PC; Wang WT; Chiu MJ; Shen CK
    Neuroscience; 2009 Mar; 159(2):638-46. PubMed ID: 19167467
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deposition of C-terminally truncated Aβ species Aβ37 and Aβ39 in Alzheimer's disease and transgenic mouse models.
    Reinert J; Richard BC; Klafki HW; Friedrich B; Bayer TA; Wiltfang J; Kovacs GG; Ingelsson M; Lannfelt L; Paetau A; Bergquist J; Wirths O
    Acta Neuropathol Commun; 2016 Mar; 4():24. PubMed ID: 26955942
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.